ahlam1399
06-18-2015, 04:04 AM
UPDATE 1-BioMarin?s dwarfism drug improves growth in a mid-stage study
June 17 (Reuters) - BioMarin Pharmaceutical Inc said its experimental drug was effective in improving growth in children with the most common form of dwarfism in a mid-stage study.http://feeds.feedburner.com/~ff/reuters/hotStocksNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=KlEBcWJfZQ4:pfmHNwcrmrw:yIl2AUoC8z A) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=KlEBcWJfZQ4:pfmHNwcrmrw:F7zBnMyn0L o (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=KlEBcWJfZQ4:pfmHNwcrmrw:F7zBnMyn0L o) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=KlEBcWJfZQ4:pfmHNwcrmrw:V_sGLiPBpW U (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=KlEBcWJfZQ4:pfmHNwcrmrw:V_sGLiPBpW U)
http://feeds.feedburner.com/~r/reuters/hotStocksNews/~4/KlEBcWJfZQ4
June 17 (Reuters) - BioMarin Pharmaceutical Inc said its experimental drug was effective in improving growth in children with the most common form of dwarfism in a mid-stage study.http://feeds.feedburner.com/~ff/reuters/hotStocksNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=KlEBcWJfZQ4:pfmHNwcrmrw:yIl2AUoC8z A) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=KlEBcWJfZQ4:pfmHNwcrmrw:F7zBnMyn0L o (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=KlEBcWJfZQ4:pfmHNwcrmrw:F7zBnMyn0L o) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=KlEBcWJfZQ4:pfmHNwcrmrw:V_sGLiPBpW U (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=KlEBcWJfZQ4:pfmHNwcrmrw:V_sGLiPBpW U)
http://feeds.feedburner.com/~r/reuters/hotStocksNews/~4/KlEBcWJfZQ4